AndreaBozzo/ceres-open-data-index huggingface dataset:
Compound 526233: 1,2,3,7-Tetrabromo-dibenzofuran

Chemical compound data from PubChem database. IUPAC Name: 1,2,3,7-tetrabromodibenzofuran. Molecular Formula: C12H4Br4O. Molecular Weight: 483.77. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
National Child Abuse and Neglect Data System (NCANDS) Child File: Findings from the National Child Abuse and Neglect Data System (NCANDS) – File Contents and Definitions for the Data Tables (updated with FY 2015)

<p>The National Child Abuse and Neglect Data System (NCANDS) Child File data set consists of child-specific data of all reports of maltreatment to State child protective service agencies that received an investigation or assessment response. NCANDS is a Federally-sponsored national data collection effort created for the purpose of tracking the volume and nature of child maltreatment reporting each year within the United States. The Child File is the case-level component of the NCANDS. Child File data are collected annually through the voluntary participation of States. Participating States submit their data after going through a process in which the State's administrative system is mapped to the NCANDS data structure.  Data elements include the demographics of children and their perpetrators, types of maltreatment, investigation or assessment dispositions, risk factors, and services provided as a result of the investigation or assessment.</p>
Compound 530136: Alanine, 2-methyl-N-(trimethylsilyl)-, trimethylsilyl ester

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl 2-methyl-2-(trimethylsilylamino)propanoate. Molecular Formula: C10H25NO2Si2. Molecular Weight: 247.48. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Treatment Episode Data Set (TEDS) 1998 - 2008 National Admissions to Substance Abuse Treatment Services

This report presents national-level data from the Treatment Episode Data Set (TEDS) for admissions in 2008 and trend data for 1998 to 2008. The report provides information on the demographic and substance abuse characteristics of people aged 12 and older admitted to treatment for abuse of alcohol and/or drugs in facilities that report to individual state administrative data systems.
National Artesunate for Severe Malaria Program Artesunate Dosing Data- April to December 2019

This dataset includes deidentified data on patients receiving artesunate through the National Artesunate for Severe Malaria Program from April- December 2019. 

This dataset contains artesunate dosing data only.
Please see the links below for the other datasets and the attached word document, 'Guide to NASMP Datasets':

Data from Case Report- https://data.cdc.gov/Global-Health/National-Artesunate-for-Severe-Malaria-Program-Cas/igaz-icki

Data on Follow-On Antimalarial Dosing- https://data.cdc.gov/Global-Health/National-Artesunate-for-Severe-Malaria-Program-Fol/g3k9-gyw7

Data on Microscopy (Parasitemia values)- https://data.cdc.gov/Global-Health/National-Artesunate-for-Severe-Malaria-Program-Mic/v2k9-ctv4

All data can be easily linked using the ParticipantID field, a unique ID number assigned to each participant.
Population Group Estimates used in the Healthy People 2020 Overview of Health Disparities

The Overview of Health Disparities analysis is a component of the Healthy People 2020 (HP2020) Final Review. The analysis included 611 objectives in HP2020. See Technical Notes for the Healthy People 2020 Overview of Health Disparities (https://www.cdc.gov/nchs/healthy_people/hp2020/health-disparities.htm) for additional information and criteria for objectives, data years, and population characteristics included in the analysis and statistical formulas and definitions for the disparities measures. 

This file contains estimates and standard errors for the baseline and final years for individual population groups used in the Overview of Health Disparities analysis. The number and definitions of population groups varied across the HP2020 objectives and data sources used. These population groups are shown in the disparities file as originally reported by the data source, rather than the harmonized categories that were used for the HP2020 Progress by Population Group analysis (https://www.cdc.gov/nchs/healthy_people/hp2020/population-groups.htm). Additionally, for any given objective, the baseline and final years used for the disparities analysis do not necessarily correspond to the baseline and final years used to evaluate progress toward target attainment in the HP2020 Final Review Progress Table (https://www.cdc.gov/nchs/healthy_people/hp2020/progress-tables.htm) and Progress by Population Group analysis (https://www.cdc.gov/nchs/healthy_people/hp2020/population-groups.htm). These distinctions should be considered when merging the downloadable Progress Table or Progress by Population Group data files with the Overview of Health Disparities data files, or when integrative analyses that incorporate both disparities and progress data are conducted.  
    
Data for additional years during the HP2020 tracking period that are not included in the Overview of Health Disparities are available on the HP2020 website (https://www.healthypeople.gov/2020/).
Patent AT-E401532-T1: [Translated] METHOD AND ARRANGEMENT FOR DETERMINING A QUANTITY OF STEAM

Process for determining an amount of steam produced in a steam generator equipped with superheaters (UE1, UE2, UE3) comprises continuously measuring the pressure loss of the last superheating phase, continuously measuring the temperature of the steam before and after the last superheating phase, continuously measuring the pressure of the steam after the last superheating phase, determining the pressure loss and the amount and volume of the steam in the steam generator when the generator has a full load and using as reference values, and determining the amount of steam of each load produced via the ratio of the measured values to the reference values.  An Independent claim is also included for a device for determining an amount of steam produced in a steam generator equipped with superheaters (UE1, UE2, UE3).
2013 NSDUH Illicit Drug Use Tables  (Prevalence Estimates) - 1.1 to 1.92

These detailed tables are population illicit drug use totals and prevalence estimates from the 2013 National Survey on Drug Use and Health (NSDUH). Illicit drugs include marijuana, cocaine, crack, heroin, hallucinogens, inhalants, and the nonmedical use of prescription-type psychotherapeutics, including pain relievers, tranquilizers, stimulants, and sedatives. Results are provided for lifetime, past year, and past month use by age group, gender, race/ethnicity, education level, employment status, and geographic area. Comparisons are made between 2013 and 2012.
Compound 526868: 2-(2-(2-Isobutoxy-ethoxy)-ethoxy)-ethoxy)-ethanol

Chemical compound data from PubChem database. IUPAC Name: 2-[2-[2-[2-(2-methylpropoxy)ethoxy]ethoxy]ethoxy]ethanol. Molecular Formula: C12H26O5. Molecular Weight: 250.33. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Treatment Episode Data Set (TEDS): 2004-2014, National Admissions To Substance Abuse Treatment Services

This report presents national-level data from the Treatment Episode Data Set (TEDS) for admissions in 2014 and trend data from 2004 to 2014. It is a companion to the report Treatment Episode Data Set (TEDS): 2004-2014 State Admissions to Substance Abuse Treatment. These reports provide information on the demographic and substance abuse characteristics of admissions aged 12 and older to treatment for abuse of alcohol and/or drugs in facilities that report to individual state administrative data systems.
Compound 529905: 1-(Prop-2-enyltrisulfanyl)prop-1-ene

Chemical compound data from PubChem database. IUPAC Name: 1-(prop-2-enyltrisulfanyl)prop-1-ene. Molecular Formula: C6H10S3. Molecular Weight: 178.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401748-T1: [Translated] METHOD AND ARRANGEMENT IN A RADIO COMMUNICATIONS SYSTEM

A method and an arrangement in a cellular radio communication network for preparing a measurement order list for transmission to a mobile station operating in a first cell. It is determined ( 502 ) whether at least one cell among the neighbouring cells is incapable of acting as a target for handoff of the mobile station. If at least one cell incapable of acting as a target for handoff is found, at least one control channel associated with such a cell is omitted when generating ( 503 ) said list by including control channels associated with neighbouring cells.
Compound 525670: p-Bromobenzylidene-hexyl-amine

Chemical compound data from PubChem database. IUPAC Name: 1-(4-bromophenyl)-N-hexylmethanimine. Molecular Formula: C13H18BrN. Molecular Weight: 268.19. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401830-T1: [Translated] IMPROVED SEALING SYSTEM FOR TROCAR

A trocar for performing a procedure on a patient. The trocar includes a hollow cannula having a distal end and a proximal end. The trocar includes a housing having a distal end attached to the proximal end of the cannula and a proximal end having a wall attached thereto. The wall having an aperture therethrough. The trocar further includes a first seal disposed within the housing comprising a plurality of layered elastomeric members forming conical shape. <IMAGE>
Patent AT-E400799-T1: [Translated] LEVEL SENSOR MOUNTING

A method for fixing a fuel level sensor in a fuel tank having an upper and a lower wall, the sensor having a foot and a top. The method fixedly secures the foot of the sensor to the bottom wall of the fuel tank through a molded-in retainer, and elastically fixes the tubular top of the sensor to the top wall of the tank through a molded-in retainer as well.
Compound 526710: 2-(2-(2-(2-(2-decyloxy-ethoxy)-ethoxy)-ethoxy)-ethoxy)-ethanol, TFA

Chemical compound data from PubChem database. IUPAC Name: 2-[2-[2-[2-(2-decoxyethoxy)ethoxy]ethoxy]ethoxy]ethyl 2,2,2-trifluoroacetate. Molecular Formula: C22H41F3O7. Molecular Weight: 474.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Chicago: Drug-Related Emergency Department Visits, 2004-2011 - All Alcohol

Excel file with estimates, rates, relative standard errors, trends and confidence intervals, covering 2004-2011 for emergency department visits involving alcohol in the Chicago metropolitan area.  For adults aged 21 and older, the alcohol was found in combination with other drugs. For patients under the age of 21, the visit may involve alcohol alone or in combination with other drugs.File includes data for over 500 drugs, including illicit drugs, prescription and over-the-counter medications, dietary supplements, inhalants and alcohol.  Includes total visits, gender, age group, race/ethnicity, outcome of visit, drug combinations, number of drugs involved in visit, drug frequency, and drugs confirmed by toxicology.Additional detail is provided for illicit drugs, psychotherapeutic drugs, central nervous system (CNS) drugs, respiratory drugs and cardiovascular drugs.
Patent AT-E400973-T1: [Translated] METHOD AND DEVICE FOR CALL DIVERSION OF A RADIO TRANSMISSION TO A WIRED TERMINAL

Apparatus, method and system for notifying a communications switching center that a subsequent communication directed to a wireless number associated with the wireless unit is to be routed to a directory number associated with the wireless unit. A converter may be provided and connected to a current source and to a communications switching center. The wireless unit may be connected to the converter, and if connected, the unit draws current therefrom. In response to the draw of current by the wireless unit through the converter, the converter transmits a message to the communications switching center. The message includes a notification that a subsequent communication directed to the wireless number associated with the wireless unit is to be routed to the directory number associated with the wireless unit.
Compound 527766: 2,2-Dichloroethyl pentadecanoate

Chemical compound data from PubChem database. IUPAC Name: 2,2-dichloroethyl pentadecanoate. Molecular Formula: C17H32Cl2O2. Molecular Weight: 339.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525609: N,N-Dimethyl-N'-(4-nitrophenyl)-p-methylbenzamidine

Chemical compound data from PubChem database. IUPAC Name: N,N,4-trimethyl-N'-(4-nitrophenyl)benzenecarboximidamide. Molecular Formula: C16H17N3O2. Molecular Weight: 283.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529045: Ethanediol, heptylboronate

Chemical compound data from PubChem database. IUPAC Name: 2-heptyl-1,3,2-dithiaborolane. Molecular Formula: C9H19BS2. Molecular Weight: 202.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Hospital Price Transparency Enforcement Activities and Outcomes

The Hospital Price Transparency Enforcement Activities and Outcomes dataset contains information related to enforcement actions taken by CMS following a compliance review of a hospital's obligation to establish, update and make public a list of the hospital’s standard charges for items and services provided by the hospital, in accordance with regulation (45 CFR 180). This data set includes the name of each hospital or hospital location, the hospital or hospital location address, the outcome or action following a CMS compliance review and the date of the outcome or action taken.
Compound 530093: 2-Chlorophenyl 2-bromopropanoate

Chemical compound data from PubChem database. IUPAC Name: trimethyl-(6-trimethylsilyloxy-2-trimethylsilylsulfanylpyrimidin-4-yl)oxysilane. Molecular Formula: C13H28N2O2SSi3. Molecular Weight: 360.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Time course of muscle soreness following different types of exercise

Background
          Post-exercise muscle soreness is a dull, aching sensation that follows unaccustomed muscular exertion. Primarily on the basis of previous laboratory-based research on eccentric exercise, soreness is usually said to follow an inverted U-shaped curve over time, peaking 24 – 48 hours after exercise. As such, it is often described as "delayed-onset" muscle soreness. In a study of long-distance runners, soreness seemed to peak immediately and then reduce gradually over time. The study is a secondary analysis of clinical trial data that aims to determine whether the time course of soreness following a natural exercise, long-distance running, is different from that following a laboratory-based exercise, bench-stepping.
        
        
          Methods
          This is a reanalysis of data from three previous clinical trials. The trials included 400 runners taking part in long-distance races and 82 untrained volunteers performing a bench-stepping test. Subjects completed a Likert scale of muscle soreness every morning and evening for the five days following their exercise.
        
        
          Results
          Interaction between trial and time is highly significant, suggesting a different time course of soreness following running and bench-stepping. 45% of subjects in the bench-stepping trial experienced peak soreness at the third or fourth follow-up (approximately 36 – 48 hours after exercise) compared to only 14% of those in the running trial. The difference between groups is robust to multivariate analysis incorporating possible confounding variables.
        
        
          Conclusion
          Soreness in runners following long-distance running follows a different time course to that in untrained individuals undertaking bench-stepping. Research on exercise taking place in the laboratory context does not necessarily generalize to exercise undertaken by trained athletes when engaged in their chosen sport.
Compound 526278: 1,3,7,9-Tetrabromo-2,6-dichloro-dibenzo-p-dioxin

Chemical compound data from PubChem database. IUPAC Name: 1,3,7,9-tetrabromo-2,6-dichlorodibenzo-p-dioxin. Molecular Formula: C12H2Br4Cl2O2. Molecular Weight: 568.7. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528129: 3-Methyl-2-methoxy-5-(2-methylpentyl)pyrazine

Chemical compound data from PubChem database. IUPAC Name: 2-methoxy-3-methyl-5-(2-methylpentyl)pyrazine. Molecular Formula: C12H20N2O. Molecular Weight: 208.3. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E401676-T1: [Translated] HIGH GAIN ANTENNA FOR WIRELESS APPLICATIONS

An antenna includes a ground plane and an active antenna element adjacent the ground plane. Passive antenna elements are adjacent the ground plane, and are spaced apart from the active antenna element. First parasitic gratings are adjacent the ground plane and are spaced apart from the active antenna element. Each first parasitic grating is between two adjacent passive antenna elements. A controller selectably controls the passive antenna elements for operating in a reflective mode or a directive mode. The controller includes for each respective passive antenna element at least one impedance element connected to the ground plane, and a switch adjacent the ground plane for connecting the at least one impedance element to the passive antenna element so that the passive antenna element operates in the reflective or directive mode.
Clinical utility of a nested nucleic acid amplification format in comparison to viral culture for the diagnosis of mucosal herpes simplex infection in a genitourinary medicine setting

Background
          Nested nucleic acid amplification tests are often thought too sensitive or prone to generatingfalse positive results for routine use. The current study investigated the specificity and clinicalutility of a routine multiplex nested assay for mucosal herpetic infections.
        
        
          Methods
          Ninety patients, categorised into those clinically diagnosed to (a) have and (b) not haveherpetic infection, were enrolled. Swabs from oral and ano-genital sites were assayed by thenested assay and culture and the results assessed against clinical evaluation for diagnosingherpetic infections; cell content was also recorded.
        
        
          Results
          Twenty-six and 64 patients were thought to (a) have and (b) not have mucosal herpeticinfection. Taking the clinical evaluation as indicating the presence of herpetic infection, thenested polymerase chain reaction and culture had respective sensitivities of 19/26 (73%) and12/26 (46%) (Χ2 p = 0.02). There was no significant difference in specificities between nPCR62/64 (97%) and culture 63/64 (98%) (Χ2 p = 1.0). Cell content was important for viraldetection by nPCR (Χ2 p = 0.07) but not culture. Nesting was found necessary for sensitivity anddid not reduce specificity. Assay under-performance appeared related to sub-optimal cellcontent (20%) but may have reflected clinical over-diagnosis. The results suggest the need forvalidating specimen cell quality.
        
        
          Conclusions
          This study questions the value of routine laboratory confirmation of mucosal herpetic infection. The adoption of a more discriminatory usage of laboratory diagnostic facilities for genital herpetic infection, taking account of cell content, and restricting it to those cases where it actually affects patient management, may be warranted.
Instructions for State Courts on Applying for State Court Improvement Program (CIP) Funds for Fiscal Year (FY) 2023

This Program Instruction (PI) provides guidance on the eligibility requirements and grant application procedures for the State CIP grant for FY 2023, including updating the five-year strategic plan, and to provide guidance on the requirements for state courts to continuously assess and improve the handling of court proceedings related to child welfare and enhance collaboration with title IV-B/IV-E agencies and tribes.

Metadata-only record linking to the original dataset. Open original dataset below.
Hospital Cost Report Audited Data: 2018

This version of the Institutional Cost Report (ICR) has been audited by a Certified Public Accounting Firm. The ICR is a uniform report completed by New York State hospitals to report income, expenses, assets, liabilities, and statistics to the Department of Health (DOH). Under DOH regulations, (Part 86-1.2), Article 28 hospitals are required to file financial and statistical data with DOH annually. The data filed is part of the ICR and is received electronically through a secured network. This data is used to develop Medicaid rates, assist in the formulation of reimbursement methodologies, and analyze trends. For more information, check out: http://www.health.ny.gov/facilities/hospital/index.htm
Compound 530181: Histamine, di-TMS

Chemical compound data from PubChem database. IUPAC Name: N-trimethylsilyl-2-(1-trimethylsilylimidazol-4-yl)ethanamine. Molecular Formula: C11H25N3Si2. Molecular Weight: 255.51. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
COVID-19 State Profile Report - Maryland

<b>After over two years of public reporting, the State Profile Report will no longer be produced and distributed after February 2023. The final release was on February 23, 2023. We want to thank everyone who contributed to the design, production, and review of this report and we hope that it provided insight into the data trends throughout the COVID-19 pandemic.
Data about COVID-19 will continue to be updated at <a href='https://covid.cdc.gov/covid-data-tracker/#datatracker-home' >CDC’s COVID Data Tracker</a>.
 </b>

<p>
The State Profile Report (SPR) is generated by the Data Strategy and Execution Workgroup in the Joint Coordination Cell, in collaboration with the White House. It is managed by an interagency team with representatives from multiple agencies and offices (including the United States Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention, the HHS Assistant Secretary for Preparedness and Response, and the Indian Health Service). The SPR provides easily interpretable information on key indicators for each state, down to the county level.
 </p>

It is a weekly snapshot in time that:
<ul>
<li>Focuses on recent outcomes in the last seven days and changes relative to the month prior</li>
<li>Provides additional contextual information at the county level for each state, and includes national level information</li>
<li>Supports rapid visual interpretation of results with color thresholds</li>
</ul>